Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the industry starts to launch drugs developed by identifying genes associated with disease.
Biotech's bull run starts to look frothy
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content